ArticleFrontiers in oncology2026

Pathological complete response to neoadjuvant TACHP in HER2-positive/HR-positive inflammatory breast cancer: a case report.

Mengjie Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.